Article Text
Now and then
Consensus statement on the initiation and continuation of tumour necrosis factor blocking therapies in rheumatoid arthritis
Statistics from Altmetric.com
Footnotes
↵* Professor Barry Bresnihan was the acting editor for this paper.
The meeting was supported by an unrestricted educational grant from Schering-Plough Corporation.